UCB4594 clinical trials

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

This study is testing a new drug, UCB4594, for advanced cancers. It's the first time it’s being used in people. Researchers want to find the safest dose, understand side effects, and see if it can shrink certain tumours by helping the body's immune system.